Literature DB >> 21139415

[Power estimation and follow-up period evaluation in Korea radiation effect and epidemiology cohort study].

In Seong Cho1, Minkyo Song, Yunhee Choi, Zhong Min Li, Yoon Ok Ahn.   

Abstract

OBJECTIVES: The objective of this study was to calculate sample size and power in an ongoing cohort, Korea radiation effect and epidemiology cohort (KREEC).
METHOD: Sample size calculation was performed using PASS 2002 based on Cox regression and Poisson regression models. Person-year was calculated by using data from '1993-1997 Total cancer incidence by sex and age, Seoul' and Korean statistical informative service.
RESULTS: With the assumption of relative risk=1.3, exposure:non-exposure=1:2 and power=0.8, sample size calculation was 405 events based on a Cox regression model. When the relative risk was assumed to be 1.5 then number of events was 170. Based on a Poisson regression model, relative risk=1.3, exposure:non-exposure=1:2 and power=0.8 rendered 385 events. Relative risk of 1.5 resulted in a total of 157 events. We calculated person-years (PY) with event numbers and cancer incidence rate in the non-exposure group. Based on a Cox regression model, with relative risk=1.3, exposure:non-exposure=1:2 and power=0.8, 136 245PY was needed to secure the power. In a Poisson regression model, with relative risk=1.3, exposure:non-exposure=1:2 and power=0.8, person-year needed was 129517PY. A total of 1939 cases were identified in KREEC until December 2007.
CONCLUSIONS: A retrospective power calculation in an ongoing study might be biased by the data. Prospective power calculation should be carried out based on various assumptions prior to the study.

Entities:  

Mesh:

Year:  2010        PMID: 21139415     DOI: 10.3961/jpmph.2010.43.6.543

Source DB:  PubMed          Journal:  J Prev Med Public Health        ISSN: 1975-8375


  1 in total

1.  Cancer risk in adult residents near nuclear power plants in Korea - a cohort study of 1992-2010.

Authors:  Yoon-Ok Ahn; Zhong Min Li
Journal:  J Korean Med Sci       Date:  2012-08-22       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.